Content type

Local Drugmakers To Benefit From Botswana-Zimbabwe Relations, But Limited Opportunities For Innovative Drugmakers

Pharma & Healthcare / Zimbabwe / Fri 04 Mar, 2022

Key View

  • Bilateral relations between Zimbabwe and Botswana are on an upward trajectory.
  • Local generic drugmakers will be the primary beneficiary to the increase in relations.
  • Potential benefits for multinational drugmakers could be realised in the longer term, but challenges remain.

Bilateral relations between Zimbabwe and Botswana on an

Read More

Growth In Zimbabwe To Remain Sluggish In 2022

Country Risk / Zimbabwe / Wed 16 Feb, 2022

Key View

  • We at Fitch Solutions expect real GDP growth in Zimbabwe to slow from an estimated 4.7% in 2021 to just 3.7% in 2022.
  • Although economic activity will be supported by private consumption, growth will be capped by base effects, slowing agricultural output, and lower commodity prices.
  • We then see real GDP growth slowing further to 3.1%
Read More

Zimbabwe's Current Account Surplus To Moderate In 2022

Country Risk / Zimbabwe / Wed 17 Nov, 2021

Key View

  • We at Fitch Solutions expect Zimbabwe’s current account surplus to narrow to 2.4% of GDP in 2021 and 1.4% in 2022, from 4.8% in 2020, as demand for consumer and industrial imports strengthens amid an uptick in economic activity.
  • While the secondary income surplus will remain substantial given ongoing aid inflows, this will be
Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.